Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549 |
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 |
Date
of Report (Date of earliest event reported)
March 9, 2010
GLOBAL MED TECHNOLOGIES, INC.
(Exact name of registrant as specified in its
charter)
| Colorado |
|
0-22083 |
|
84-1116894 |
| (State or other jurisdiction of |
|
(Commission File No.) |
|
(I.R.S. Employer |
| incorporation or organization) |
|
|
|
Identification No.) |
|
|
| 12600 West Colfax,
Suite C-420, Lakewood, Colorado |
|
80215 |
| (Address of principal executive offices) |
|
(Zip Code) |
|
|
|
|
| (303)
238-2000 |
| (Registrant’s telephone number, including area
code) |
| |
|
|
| Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the |
| registrant under any of the following
provisions: |
|
|
|
|
| ¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425) |
|
|
| ¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
|
|
| ¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
|
| ¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR
240.13e-4(c)) |
On
March 9, 2010, Global Med Technologies, Inc. issued a press release with respect
to its fourth-quarter and fiscal year 2009 results. The press release is
attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
| Item 9.01.
Financial Statements and Exhibits. |
|
|
(a) |
Not applicable |
|
|
|
|
|
(b) |
Not applicable |
|
|
|
|
|
(c) |
Not applicable |
|
|
|
|
|
(d) |
Exhibits. |
|
|
|
|
|
|
99.1
Press Release dated March 9, 2010 |
|
|
|
- 2
-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
GLOBAL MED TECHNOLOGIES,
INC.
|
|
|
|
|
|
|
| |
|
|
|
By: /s/ Michael I. Ruxin,
M.D. |
| |
|
|
|
Michael I. Ruxin, M.D. |
| |
|
|
|
Chairman
and Chief Executive
Officer |
| |
| Date: March
9, 2010 |
|
|
|
|
- 3
-
| Exhibit
No. |
|
Description
|
|
|
|
|
| 99.1 |
|
Press Release dated March 9, 2010 |
| |
- 4
-